168 related articles for article (PubMed ID: 18197813)
1. An altered peptide ligand of type II collagen suppresses autoimmune arthritis.
Myers LK; Tang B; Rosioniec EF; Stuart JM; Kang AH
Crit Rev Immunol; 2007; 27(4):345-56. PubMed ID: 18197813
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a peptide analog of a determinant of type II collagen that suppresses collagen-induced arthritis.
Myers LK; Tang B; Rosloniec EF; Stuart JM; Chiang TM; Kang AH
J Immunol; 1998 Oct; 161(7):3589-95. PubMed ID: 9759881
[TBL] [Abstract][Full Text] [Related]
3. Characterization of signal transduction through the TCR-zeta chain following T cell stimulation with analogue peptides of type II collagen 260-267.
Tang B; Myers LK; Rosloniec EF; Whittington KB; Stuart JM; Kang AH
J Immunol; 1998 Apr; 160(7):3135-42. PubMed ID: 9531268
[TBL] [Abstract][Full Text] [Related]
4. T cell receptor signaling induced by an analog peptide of type II collagen requires activation of Syk.
Tang B; Zhou J; Park JE; Cullins D; Yi AK; Kang AH; Stuart JM; Myers LK
Clin Immunol; 2009 Oct; 133(1):145-53. PubMed ID: 19596610
[TBL] [Abstract][Full Text] [Related]
5. Peptide-induced suppression of collagen-induced arthritis in HLA-DR1 transgenic mice.
Myers LK; Sakurai Y; Tang B; He X; Rosloniec EF; Stuart JM; Kang AH
Arthritis Rheum; 2002 Dec; 46(12):3369-77. PubMed ID: 12483744
[TBL] [Abstract][Full Text] [Related]
6. A synthetic peptide analogue of a determinant of type II collagen prevents the onset of collagen-induced arthritis.
Myers LK; Rosloniec EF; Seyer JM; Stuart JM; Kang AH
J Immunol; 1993 May; 150(10):4652-8. PubMed ID: 8482852
[TBL] [Abstract][Full Text] [Related]
7. T cells stimulated with an analog peptide of type II collagen require the Fc receptor γ-chain to secrete interleukin-4 and suppress autoimmune arthritis in mice.
Myers LK; Cullins DL; Brand DD; Kleinau S; Stuart JM; Kang AH
Arthritis Rheum; 2011 Sep; 63(9):2661-70. PubMed ID: 21590683
[TBL] [Abstract][Full Text] [Related]
8. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the Syk-Dependent T Cell Signaling Response to an Altered Peptide.
Park JE; Rotondo JA; Cullins DL; Brand DD; Yi AK; Stuart JM; Kang AH; Myers LK
J Immunol; 2016 Dec; 197(12):4569-4575. PubMed ID: 27837109
[TBL] [Abstract][Full Text] [Related]
10. Depletion of collagen II-reactive T cells and blocking of B cell activation prevents collagen II-induced arthritis in DBA/1j mice.
Zhang HG; Yang P; Xie J; Liu Z; Liu D; Xiu L; Zhou T; Wang Y; Hsu HC; Mountz JD
J Immunol; 2002 Apr; 168(8):4164-72. PubMed ID: 11937577
[TBL] [Abstract][Full Text] [Related]
11. Immunization with TCR Vbeta10 peptide reduces the frequency of type-II collagen-specific Th1 type T cells in BUB/BnJ (H-2q) mice.
Anthony DD; Heeger PS; Haqqi TM
Clin Exp Rheumatol; 2001; 19(4):385-94. PubMed ID: 11491493
[TBL] [Abstract][Full Text] [Related]
12. Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells.
Nandakumar KS; Bäcklund J; Vestberg M; Holmdahl R
Arthritis Res Ther; 2004; 6(6):R544-50. PubMed ID: 15535832
[TBL] [Abstract][Full Text] [Related]
13. Peptide ligand structure and I-Aq binding avidity influence T cell signaling pathway utilization.
Myers LK; Cullins DL; Park JE; Yi AK; Brand DD; Rosloniec EF; Stuart JM; Kang AH
Clin Immunol; 2015 Oct; 160(2):188-97. PubMed ID: 25982319
[TBL] [Abstract][Full Text] [Related]
14. Visualization and phenotyping of proinflammatory antigen-specific T cells during collagen-induced arthritis in a mouse with a fixed collagen type II-specific transgenic T-cell receptor β-chain.
Merky P; Batsalova T; Bockermann R; Dzhambazov B; Sehnert B; Burkhardt H; Bäcklund J
Arthritis Res Ther; 2010; 12(4):R155. PubMed ID: 20682070
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis for T cell response induced by altered peptide ligand of type II collagen.
Park JE; Cullins D; Zalduondo L; Barnett SL; Yi AK; Kleinau S; Stuart JM; Kang AH; Myers LK
J Biol Chem; 2012 Jun; 287(23):19765-74. PubMed ID: 22511761
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of modified recombinant type II collagen in modulating autoimmune arthritis.
Myers LK; Tang B; Brand DD; Rosloniec EF; Stuart JM; Kang AH
Arthritis Rheum; 2004 Sep; 50(9):3004-11. PubMed ID: 15457470
[TBL] [Abstract][Full Text] [Related]
17. T cell immunity to type II collagen in the biobreeding rat: the identification and characterization of RT1u-restricted T cell epitopes on alpha 1(II).
Cremer MA; Ye XJ; Myers LK; Brand DD; Rosloniec EF; Kang AH
J Immunol; 2004 Aug; 173(3):1795-801. PubMed ID: 15265910
[TBL] [Abstract][Full Text] [Related]
18. A transient post-translationally modified form of cartilage type II collagen is ignored by self-reactive T cells.
Yamada H; Dzhambazov B; Bockermann R; Blom T; Holmdahl R
J Immunol; 2004 Oct; 173(7):4729-35. PubMed ID: 15383610
[TBL] [Abstract][Full Text] [Related]
19. Tracking of proinflammatory collagen-specific T cells in early and late collagen-induced arthritis in humanized mice.
Svendsen P; Andersen CB; Willcox N; Coyle AJ; Holmdahl R; Kamradt T; Fugger L
J Immunol; 2004 Dec; 173(11):7037-45. PubMed ID: 15557201
[TBL] [Abstract][Full Text] [Related]
20. Differential activities of immunogenic collagen type II peptides in the induction of nasal tolerance to collagen-induced arthritis.
Chu CQ; Londei M
J Autoimmun; 1999 Feb; 12(1):35-42. PubMed ID: 10028020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
